Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. News
  7. Summary
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Report
End-of-day quote Korea Stock Exchange  -  2023-01-26
27000.00 KRW   -0.18%
2022Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on September 28, 2022.
CI
2022Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
2022Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

05/16/2022 | 04:41am EST

Seegene, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 451,451.76 million compared to KRW 351,750.09 million a year ago. Net income was KRW 165,472.01 million compared to KRW 164,627.19 million a year ago. Basic earnings per share from continuing operations was KRW 3,195 compared to KRW 3,167 a year ago. Basic earnings per share was KRW 3,195 compared to KRW 3,167 a year ago.


ę S&P Capital IQ 2022
All news about SEEGENE, INC.
2022Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on September 28, 2022.
CI
2022Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
2022Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.
CI
2022Seegene, Inc. authorizes a Buyback Plan.
CI
2022Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 4, 2022.
CI
2022Seegene, Inc.'s Equity Buyback announced on March 4, 2022, has expired with 1,137,640 s..
CI
2022Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June..
CI
2022Seegene reports H1 2022 financial results
AQ
2022Seegene unveils strategies for global expansion at 2022 AACC
AQ
2022Seegene launches world's first In-life PCR campaign in Vietnam
AQ
More news
Financials
Sales 2022 882 B 0,72 B 0,72 B
Net income 2022 209 B 0,17 B 0,17 B
Net cash 2022 516 B 0,42 B 0,42 B
P/E ratio 2022 6,75x
Yield 2022 2,75%
Capitalization 1 343 B 1 090 M 1 090 M
EV / Sales 2022 0,94x
EV / Sales 2023 1,28x
Nbr of Employees 1 008
Free-Float 65,8%
Chart SEEGENE, INC.
Duration : Period :
Seegene, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEEGENE, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 27 000,00 KRW
Average target price 36 000,00 KRW
Spread / Average Target 33,3%
EPS Revisions
Managers and Directors
Jong-Yoon Chun Chief Executive Officer & Director
Jin-Soo Choi President & General Manager-Management
Kyung-O Min President & Head-Research
Min-Chul Lee President, Head-Research & Development
Ho Lee President & Head-Sales
Sector and Competitors
1st jan.Capi. (M$)
SEEGENE, INC.-0.74%1 089
EXACT SCIENCES CORPORATION29.77%11 557
BGI GENOMICS CO., LTD.5.57%3 298
GUARDANT HEALTH, INC.16.29%3 183
VERACYTE, INC.8.51%1 870
BEIJING STRONG BIOTECHNOLOGIES, INC.3.05%1 460